Skip to content

Clinical trials

Terminated Phase 2 Neuralgia trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Neuralgia Phase: Phase 2 Status: Terminated Clear all

32 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20041
20082
20096
20102
20111
20122
20131
20142
20151
20162
20171
20182
20191
20202
20211
20221
20231
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated32

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Grünenthal GmbH3
AstraZeneca2
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.2
Novartis Pharmaceuticals2
Allergan1
Bayer1
Beth Israel Medical Center1
Danish Pain Research Center1
Dr. Yoram Shir1
GlaxoSmithKline1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Neuralgia32
Pain11
Diabetic Neuropathies7
Agnosia5
Neuralgia, Postherpetic4
Chronic Pain3
Diabetes Mellitus3
Facial Pain3
Peripheral Nervous System Diseases3
Herpes Zoster2

Trials

Showing 1 to 25 of 32. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.